Btk inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.
Merck Sharp & Dohme Corp.
A A C A A
A61P A61K C07D A61K A61K
inventional inventional inventional inventional additional
Sobhana Babu Jiaqiang Shilan Jian Deodial Guy Chundao Joseph A. Dahai Xiaolei Hao
Boga Cai Liu Liu Guiadeen Yang Kozlowski Wang Gao Wu